Clinical Trial Update: Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

View source ↗

Summary

A Shanghai Chest Hospital study is evaluating neoadjuvant chemoimmunotherapy followed by robotic pulmonary resection for stage IIB–III non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection | Status: RECRUITING